⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
Pomerantz LLP Notifies Shareholders of Class Action Filing Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
The Gross Law Firm Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX
prnewswire.com
TLX
Shareholders of Telix Pharmaceuticals Ltd. (TLX): Protect Your Rights Before January 9, 2026 - Contact Levi & Korsinsky
accessnewswire.com
TLX
TLX FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - TLX
accessnewswire.com
TLX
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
globenewswire.com
TLX
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
TLX
Pomerantz LLP Issues Reminder to Shareholders in Telix Pharmaceuticals Limited of Class Action Lawsuit – TLX
accessnewswire.com
TLX
Securities Class Action Lawsuit Filed Against Telix Pharmaceuticals Ltd. (TLX) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
TLX
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals
businesswire.com
TLX